• Medical Devices
  • Friday, 26 Jun 2020

Continuous blood sugar monitoring: The digital "patch" from Menarini Diagnostics is now available

Publisher: The Insight Partners

With a conventional blood glucose meter, patients had to prick their fingers and take a drop of blood up to ten times a day, sometimes even at night. With GlucoMen® Day, Menarini Diagnostics will change the lives of thousands of people who no longer have to repeat this unpleasant routine. Needles and stitches are exchanged for a new device in the form of a plaster that can be worn continuously for two weeks. In addition, the people who use it can view their blood sugar level at any time of the day directly via the app installed on their smartphone. The user will also be able, depending on his specific needs, to set warnings that will help him monitor the values ??if they exceed the safe limits.

The statistics and charts that appear on the app can be shared in real time with family members, caregivers, and most importantly, with doctors who are able to remotely monitor the patient, personalize the therapy, and tailor it to specific Adapt to needs. Immediate sharing will greatly help achieve clinical goals, save energy and time, reduce travel, and increase patient awareness, who will be increasingly motivated to actively care for their health.

This new technology is in line with new trends in telemedicine, which is rapidly transforming the world of healthcare, and with the stormy digital revolution that has been accelerated by the current pandemic.

The system is now available through affiliates of the group across Europe and through its export network even in areas not directly covered by Menarini offices.

“ We are proud of this important milestone that was achieved thanks to the extraordinary passion and determination of our team. GlucoMen® Day is an innovative system and will help improve the quality of life for people with diabetes. It will enable them to live more calmly and freely, "commented Fabio Piazzalunga, Global Head of Menarini Diagnostics.


Related News